Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Volume 26, Issue 11, Pages 1387-1395
Publisher
Springer Nature
Online
2011-05-06
DOI
10.1007/s00384-011-1229-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications
- (2010) Antoine Italiano et al. ANNALS OF SURGICAL ONCOLOGY
- Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
- (2010) Inti Zlobec et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
- (2010) Sun Lee et al. PATHOLOGY INTERNATIONAL
- KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
- (2009) Garrett M. Nash et al. ANNALS OF SURGICAL ONCOLOGY
- KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
- (2009) Garrett M. Nash et al. ANNALS OF SURGICAL ONCOLOGY
- KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy
- (2009) Ahmad D. Siddiqui et al. ANNALS OF SURGICAL ONCOLOGY
- Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
- (2009) K. Kumar et al. CLINICAL CANCER RESEARCH
- BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients
- (2009) Yasuhiro ITO et al. ENDOCRINE JOURNAL
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
- (2009) Salvatore Siena et al. JNCI-Journal of the National Cancer Institute
- Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
- (2008) Xiaolong Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator Phenotype
- (2008) D. R. English et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
- (2008) L. Barault et al. CANCER RESEARCH
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- Asia Pacific consensus recommendations for colorectal cancer screening
- (2008) J J Y Sung et al. GUT
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: Results from the Netherlands Cohort Study
- (2008) M.P. Weijenberg et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- PIK3CAcancer mutations display gender and tissue specificity patterns
- (2007) Silvia Benvenuti et al. HUMAN MUTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started